two new protease inhibitors for hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir)

You'll see two new protease inhibitors for hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir).

That's right...protease inhibitors for hep C.

These are "game changers." They lead to much higher cure rates and shortened treatment duration. They're ADDED to pegylated interferon and ribavirin for genotype 1 hep C.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote